241 related articles for article (PubMed ID: 21086786)
1. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
2. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
[TBL] [Abstract][Full Text] [Related]
3. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
[TBL] [Abstract][Full Text] [Related]
6. 5-aza-CdR induces the demethylation of Syk promoter in nasopharyngeal carcinoma cell.
Jin Q; Liu C; Yan C; Tao B; Li Z; Cai Z
Gene; 2012 Dec; 511(2):224-6. PubMed ID: 23036706
[TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
[TBL] [Abstract][Full Text] [Related]
9. [Effect of spleen tyrosine kinase expression re-activation by inhibition of DNA methylation on oncogenesis growth of gastric cancer].
Ding YB; Xia JG; Chen GY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):523-6. PubMed ID: 17143801
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
13. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia.
Goodman PA; Burkhardt N; Juran B; Tibbles HE; Uckun FM
Oncogene; 2003 Apr; 22(16):2504-14. PubMed ID: 12717427
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
18. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
19. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]